BIOMAT Database Logo BIOMAT Database Logo

[Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)]. 1987

B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002969 Clavulanic Acids Acids, salts, and derivatives of clavulanic acid (C8H9O5N). They consist of those beta-lactam compounds that differ from penicillin in having the sulfur of the thiazolidine ring replaced by an oxygen. They have limited antibacterial action, but block bacterial beta-lactamase irreversibly, so that similar antibiotics are not broken down by the bacterial enzymes and therefore can exert their antibacterial effects. Acids, Clavulanic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].
January 1987, Archivio Monaldi per le malattie del torace,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
Drug allergy to the beta-lactam antibiotics clavulanic acid and amoxicillin.
January 1997, Allergy,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Prophylactic antibiotic therapy with amoxicillin-clavulanic acid in oropharyngeal surgery].
January 1995, Acta otorrinolaringologica espanola,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
January 1990, Minerva pediatrica,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Amoxicillin with clavulanic acid - standard antibiotic in general dentistry].
September 2017, Swiss dental journal,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
Susceptibility of bacterial respiratory pathogens to amoxicillin and amoxicillin-clavulanic acid.
May 1994, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
Acquired resistance of Nocardia brasiliensis to clavulanic acid related to a change in beta-lactamase following therapy with amoxicillin-clavulanic acid.
March 1991, Antimicrobial agents and chemotherapy,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Amoxicillin/clavulanic acid].
August 2000, Deutsche medizinische Wochenschrift (1946),
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.
May 1977, Antimicrobial agents and chemotherapy,
B Palermo, and S Rizza, and M P Pistorio, and N Crimi, and C Maccarrone, and A Mistretta
[Amoxicillin-clavulanic acid hepatotoxicity].
February 1998, Gastroenterologia y hepatologia,
Copied contents to your clipboard!